Scopri le migliori cliniche e prezzi di Radioembolizzazione per il cancro al fegato in Italia 2026

Radioembolization (SIRT) is available in Italy for treating primary liver cancer and colorectal metastases. Leading university hospitals and research institutes in Milan and Rome utilize Yttrium-90 microspheres (SIR-Spheres). These centers provide advanced interventional radiology for patients who are not candidates for surgery.

• Available technology: Clinics use Yttrium-90 microspheres to deliver targeted internal radiation therapy.
• Major centers: San Raffaele Hospital in Milan performs over 52,000 surgeries annually.
• Treatment goal: Surgeons use SIRT to downstage tumors for future resection or transplant.
• Specialist care: Interventional radiologists perform the procedure across two or three hospital sessions.

Bookimed Expert Insight: While Italy hosts top-tier research hospitals like San Raffaele, specialized SIRT availability is regionally concentrated. Large institutes often combine research with care, giving patients access to the latest clinical protocols. Patients should confirm which specific microsphere brand a hospital stocks before traveling for treatment.

Patient Consensus: Patients recommend contacting major centers like the National Cancer Institute directly to confirm current availability. Many suggest considering private options or cross-border care to avoid longer wait times in the public system.

Radioembolization is a two-step outpatient procedure for liver cancer involving a mapping session and Y-90 radioactive bead injection. Interventional radiologists guide a catheter via the groin or wrist into liver blood vessels. Microscopic beads then deliver targeted radiation directly to the tumor.

• Mapping session: A tracer simulation ensures beads will not leak into other organs.
• Treatment injection: Millions of Y-90 microspheres lodge in tumor vessels 1–2 weeks later.
• Typical duration: The mapping requires 1 hour followed by a 2–4 hour treatment.
• Radiation precautions: Patients avoid close contact with children for 3–5 days after infusion.

Bookimed Expert Insight: Italian research centers like San Raffaele in Milan combine clinical care with intensive IRCCS research. This ensures patients access specific technical expertise for complex vessel mapping. Some Italian clinics perform over 52,000 surgeries yearly, providing high volume confidence for this precise intervention.

Patient Consensus: Travelers often highlight that systemic side effects are minimal compared to traditional chemotherapy. Most feel ready for light activity within 1 week despite temporary fatigue or mild abdominal pain.

Radioembolization with Yttrium-90 serves as an effective bridge to liver transplant by controlling tumor growth. This locoregional therapy prevents waitlist dropout and downstages large tumors to meet Milan criteria. It currently surpasses traditional chemoembolization as the most utilized bridging method for hepatocellular carcinoma.

• Tumor control: It achieves high complete pathological necrosis rates compared to other methods.
• Survival rates: Bridged patients demonstrate strong long-term outcomes with 77% to 79% 5-year survival.
• Liver hypertrophy: The procedure stimulates growth in healthy liver tissue to help recovery.
• Functional status: Candidates typically require a Child-Pugh Class A or B liver score.

Bookimed Expert Insight: Italian research hospitals like San Raffaele in Milan combine clinical assistance with IRCCS research accreditation. Our data shows these centers manage over 52,000 operations annually. They often lead in multidisciplinary reviews for complex bridging cases. This research-heavy environment provides faster access to the latest protocols for patients with high tumor burdens.

Patient Consensus: Treatment can sustain waitlist eligibility for over 18 months by shrinking tumors significantly. Patients advise monitoring liver function closely as post-radiation fatigue can mimic liver failure symptoms.

Italy features world-class centers for radioembolization, specifically in Milan and Rome. Top facilities like San Raffaele Hospital and Policlinico Gemelli utilize multidisciplinary teams. These research-heavy institutions (IRCCS) provide Yttrium-90 (Y90) therapy and advanced SIRT under precise instrumental guidance for complex liver cases.

• San Raffaele Hospital: High-volume Milan center performing 52,000 surgeries annually with IRCCS research accreditation.
• Policlinico Gemelli: Rome-based leader conducting over 200 SIRT procedures yearly with documented expertise.
• Istituto Nazionale Tumori: Specialized cancer hub in Rome focusing on improved tumor response rates.
• Humanitas Research Hospital: Milan-area facility using joint hepatologist and nuclear medicine teams for safety.

Bookimed Expert Insight: Data suggests focusing on high-volume hubs like Policlinico Gemelli and San Raffaele. These centers manage 100+ cases yearly. High volume tracks directly with lower post-procedure fatigue rates. At specialized hubs, fatigue drops significantly compared to smaller clinics. Choosing these IRCCS centers ensures access to mandatory national outcome registries.

Patient Consensus: Patients emphasize the importance of the pre-procedure mapping angiogram to prevent delays. Many recommend seeking a second opinion on dosimetry simulations to ensure accuracy.